| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 30.038 | 136.275 | 54.184 | 26.842 | 35.988 | 47.875 | 64.223 | 51.732 | 130.016 |
| Total Income - EUR | - | 30.047 | 136.279 | 58.400 | 27.217 | 36.219 | 47.952 | 64.317 | 52.023 | 130.017 |
| Total Expenses - EUR | - | 7.464 | 18.209 | 17.310 | 21.946 | 19.186 | 16.930 | 7.600 | 12.041 | 24.304 |
| Gross Profit/Loss - EUR | - | 22.582 | 118.070 | 41.090 | 5.271 | 17.033 | 31.022 | 56.717 | 39.982 | 105.713 |
| Net Profit/Loss - EUR | - | 21.681 | 116.584 | 39.468 | 4.490 | 16.039 | 29.638 | 55.077 | 39.501 | 101.890 |
| Employees | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Mepemed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 451 | 21.959 | 14.832 | 8.078 | 2.212 | 767 | 1.706 | 18.891 |
| Current Assets | - | 25.696 | 137.666 | 33.274 | 34.071 | 11.505 | 28.029 | 55.018 | 25.483 | 106.575 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 2.787 | 15.151 | 5.160 | 1.912 | 1.876 | 27.440 | 32.960 | 12.933 | 57.537 |
| Cash | - | 22.909 | 122.516 | 28.114 | 32.159 | 9.630 | 589 | 22.057 | 12.550 | 49.038 |
| Shareholders Funds | - | 21.726 | 116.671 | 39.554 | 43.278 | 16.122 | 29.719 | 55.158 | 23.040 | 99.625 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 3.970 | 21.446 | 15.702 | 5.740 | 3.461 | 522 | 626 | 4.150 | 25.841 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Mepemed Srl